BioPorto A/S (BIOPOR.CO)
- Previous Close
1.2340 - Open
1.2100 - Bid 1.2360 x --
- Ask 1.2400 x --
- Day's Range
1.2100 - 1.2400 - 52 Week Range
1.0700 - 3.8500 - Volume
250,095 - Avg. Volume
748,388 - Market Cap (intraday)
470.775M - Beta (5Y Monthly) 1.19
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1600 - Earnings Date May 8, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
5.00
BioPorto A/S, an in-vitro diagnostics company, provides biomarker tools and antibodies for clinical research in Europe, North America, Asia, and internationally. It offers the neutrophil gelatinase-associated lipocalin test, a quantitative particle-enhanced turbidimetric immunoassay designed to run on automated clinical chemistry analyzers; monoclonal antibodies for scientific, pharmaceutical, and clinical research; and enzyme-linked immunosorbent assay kits, as well as generic rapid assay device for custom lateral flow assays. BioPorto A/S was incorporated in 1917 and is based in Hellerup, Denmark.
bioporto.com29
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BIOPOR.CO
Performance Overview: BIOPOR.CO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BIOPOR.CO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BIOPOR.CO
Valuation Measures
Market Cap
470.78M
Enterprise Value
411.62M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
14.36
Price/Book (mrq)
7.83
Enterprise Value/Revenue
13.30
Enterprise Value/EBITDA
-7.10
Financial Highlights
Profitability and Income Statement
Profit Margin
-181.95%
Return on Assets (ttm)
-37.90%
Return on Equity (ttm)
-86.40%
Revenue (ttm)
30.96M
Net Income Avi to Common (ttm)
-56.33M
Diluted EPS (ttm)
-0.1600
Balance Sheet and Cash Flow
Total Cash (mrq)
66.4M
Total Debt/Equity (mrq)
12.05%
Levered Free Cash Flow (ttm)
-35.37M
Research Analysis: BIOPOR.CO
Company Insights: BIOPOR.CO
BIOPOR.CO does not have Company Insights